Table 3.
Adverse effects between the two groups
| Group P (n=35) | Group E (n=35) | P* | |
|---|---|---|---|
| Pain | 12 (34.3%) | 3 (8.6%) | <0.001 |
| Myoclonus | 0 | 25.8% | 0.016 |
| Apnoea | 29 (82.9%) | 10 (28.6%) | <0.001 |
| PONV | 0 (0.0%) | 2 (5.7%) | 0.493 |
| Hypotension | 31 (88.6%) | 2 (5.7%) | <0.001 |
| Hypertension | 1 | 4 | 0.114 |
*P<0.05 is significant